ChemDiv

San Diego, United States Founded: 1990 • Age: 36 yrs
Integrated preclinical services from target to clinic stage are provided.

About ChemDiv

ChemDiv is a company based in San Diego (United States) founded in 1990. The company has 14 employees. ChemDiv operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.

  • Headquarter San Diego, United States
  • Employees 14
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website chemdiv.com
  • Social LinkedIn X Facebook
  • Legal Name Chemdiv, Inc.
Key Metrics
  • Latest Funding Round
    $274.88K (USD), Grant

    Sep 2006

  • Investors
  • Employee Count
    14

Funding Insights of ChemDiv

  • Total Rounds 1
  • Last Round Grant β€” $274,878
  • First Round $274,878

    (Sep 2006)

  • Investors Count 1

All 1 funding rounds of ChemDiv with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2006$274,878Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in ChemDiv

ChemDiv has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for ChemDiv

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ChemDiv

2 dated milestones of ChemDiv across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded ChemDiv is founded.
  2. Funding First funding round of $275K.

Competitors of ChemDiv

ChemDiv operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
evotec.com1993Hamburg, Germany$25M252
Drug discovery and development services are provided to biopharma sector.
crownbio.com2006Santa Clara, United States$85.87M18
Cancer and CVMD drugs are developed using PDX models.
alloytx.com2017Lexington, United States$117M–
Drug discovery services are provided for therapeutic development.
domainex.co.uk2001Cambridge, United Kingdom$4.97M93
Drug discovery CRO company for epigenetic research and inflammatory diseases
nih.gov1887United States––
Drug discovery services are provided to the biopharma sector.
vivabiotech.com2006Shanghai, China––
Drug discovery and development research services are provided.
catsci.com2010Cardiff, United Kingdom$5.89M63
Drug discovery services are provided to pharmaceutical clients worldwide.
qyuns.net2015Taizhou, China$66.35M–
Drug development services are provided to the biopharma sector.
conceptlifesciences.com2014Manchester, United Kingdom––
International laboratory testing and consultancy in life sciences are offered.
staqpharma.com2018Denver, United States$33.52M30
Drug discovery services are provided for pharmaceutical innovation.
Premium access

Detailed competitors of ChemDiv

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ChemDiv

The website of ChemDiv (chemdiv.com) receives about 20.9K visits a month and ranks #1,521,986 among all websites worldwide, #2,010 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    20.9K

    ▲ 32.7% vs previous month

  • Unique visitors
    6.8K

    per month

  • Global rank
    #1,521,986

    among all websites

  • Category rank
    #2,010

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with ChemDiv. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
berlex.com
berlex.com
100%
–––
calyxindia.com
100%
1K#7,901,342View details
salusint.com.pl
100%
–#2,919,064View details
belcoindia.com
100%
–#2,738,256View details
petrone.it
petrone.it
100%
–––
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 19 similar websites and full traffic analytics for ChemDiv

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Chemdiv

Premium access

Complete news archive for ChemDiv

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to ChemDiv

10 companies that operate in the same segment as ChemDiv (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ChemDiv

ChemDiv was founded in 1990 and raised its 1st funding round 16 years after it was founded.

ChemDiv is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

ChemDiv has 14 employees.

ChemDiv is an integrated preclinical development CRO, with expertise in discovery chemistry. Their integrated service portfolio includes the entire gamut of preclinical development services including synthetic chemistry, structural biology and structure-based drug discovery, molecular modelling, medicinal chemistry, scale-up, biochemical and cellular assay development, analyticalbioanalytical platforms, ADMEtox, DMPK and multiple in vivo efficacytox models. The company has a 1.5M collection of lead and drug-like small molecule compounds. ChemDiv has RD subsidiaries in Russia, Ukraine and China. They claim to have experience in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The company has a collaboration with Janssen, through which ChemDiv gives Janssen access to its small molecule discovery platform.

ChemDiv's top competitors include Evotec, Crown Bioscience and NIH.

ChemDiv has 1 investor. Key investors include HHS.

ChemDiv operates through Chemdiv, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available